Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A | Erlotinib | 10 | uM | 8 | 5000.00 | 1432.23 | 4026.33 | 11761.58 | 0.3425 | 0.4051 |
| MCF 10A | Erlotinib | 19.9526 | uM | 8 | 5000.00 | 1432.23 | 3616.33 | 11761.58 | 0.3075 | 0.3564 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 8 | 156.25 | 36.27 | 140.67 | 112.25 | 1.2480 | 1.2849 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 8 | 156.25 | 36.27 | 108.33 | 112.25 | 0.9889 | 0.9993 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 8 | 156.25 | 36.27 | 160.67 | 112.25 | 1.4288 | 1.4924 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 8 | 156.25 | 36.27 | 129.00 | 112.25 | 1.1905 | 1.2458 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 8 | 156.25 | 36.27 | 142.33 | 112.25 | 1.2413 | 1.2453 |
| SK-BR-3 | Erlotinib | 1 | uM | 8 | 156.25 | 36.27 | 113.67 | 112.25 | 1.0064 | 0.9957 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 8 | 156.25 | 36.27 | 114.33 | 112.25 | 1.0348 | 1.0545 |
| SK-BR-3 | Erlotinib | 10 | uM | 8 | 156.25 | 36.27 | 83.00 | 112.25 | 0.7498 | 0.6757 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 8 | 156.25 | 36.27 | 202.33 | 112.25 | 1.8120 | 1.8900 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 8 | 312.50 | 180.33 | 364.00 | 284.83 | 1.2751 | 1.9000 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 8 | 312.50 | 180.33 | 339.67 | 284.83 | 1.1918 | 1.6592 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 8 | 312.50 | 180.33 | 354.67 | 284.83 | 1.2536 | 1.9319 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 8 | 312.50 | 180.33 | 391.33 | 284.83 | 1.3919 | 2.6217 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 8 | 312.50 | 180.33 | 321.33 | 284.83 | 1.1339 | 1.5122 |
| SK-BR-3 | Erlotinib | 1 | uM | 8 | 312.50 | 180.33 | 275.67 | 284.83 | 0.9706 | 0.9389 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 8 | 312.50 | 180.33 | 302.00 | 284.83 | 1.0653 | 1.2454 |
| SK-BR-3 | Erlotinib | 10 | uM | 8 | 312.50 | 180.33 | 226.67 | 284.83 | 0.8004 | 0.4426 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 8 | 312.50 | 180.33 | 361.00 | 284.83 | 1.2606 | 1.8860 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 8 | 625.00 | 384.25 | 819.33 | 815.58 | 1.0021 | 0.9959 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 8 | 625.00 | 384.25 | 853.67 | 815.58 | 1.0494 | 1.0983 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 8 | 625.00 | 384.25 | 960.00 | 815.58 | 1.1743 | 1.3110 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 8 | 625.00 | 384.25 | 978.33 | 815.58 | 1.2003 | 1.3697 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 8 | 625.00 | 384.25 | 763.00 | 815.58 | 0.9361 | 0.8810 |